Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Safe Supply Streaming Portfolio Company Safety Strips, Provides Corporate Update (click to learn more) Saturn Oil & Gas Inc. Announces $525 Million Accretive Core-Area Saskatchewan Asset Acquisition (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Ekso Bionics Holdings Inc EKSO

Healthcare Medical Devices
Ekso Bionics Holdings, Inc. designs, develops, and markets exoskeleton products. Its exoskeleton technology serves multiple markets and can be utilized both by able-bodied persons and persons with physical disabilities or impairments. Its products include EksoNR, which is a wearable robotic exoskeleton specifically designed to be used in a rehabilitation setting; Ekso Indego Therapy is a... see more

Recent & Breaking News (NDAQ:EKSO)

Ekso Bionics Reports Fourth Quarter and Year End 2022 Results

GlobeNewswire March 28, 2023

Ekso Bionics to Report Fourth Quarter and Full Year 2022 Financial Results on March 28, 2023

GlobeNewswire March 20, 2023

Ekso Bionics to Showcase Integrated Functional Electrical Stimulation for Indego Therapy at APTA Meeting

GlobeNewswire February 23, 2023

Ekso Bionics Announces Acquisition of Human Motion and Control Business Unit Including Indego® Product Line From Parker Hannifin Corporation

GlobeNewswire December 5, 2022

Ekso Bionics Reports Third Quarter 2022 Results

GlobeNewswire November 3, 2022

Ekso Bionics to Report Third Quarter 2022 Financial Results on November 3, 2022

GlobeNewswire October 27, 2022

Ekso Bionics to Present at H.C. Wainwright 24th Annual Global Investment Conference

GlobeNewswire September 6, 2022

Ekso Bionics Reports Second Quarter 2022 Results

GlobeNewswire July 28, 2022

Ekso Bionics to Report Second Quarter 2022 Financial Results on July 28

GlobeNewswire July 21, 2022

Ekso Bionics Receives FDA Clearance to Market its EksoNR(TM) Robotic Exoskeleton for Use with Multiple Sclerosis Patients

GlobeNewswire June 13, 2022

Ekso Bionics Appoints Jerome Wong Interim Chief Financial Officer

GlobeNewswire May 26, 2022

Ekso Bionics to Present at the H.C. Wainwright Global Investment Conference

GlobeNewswire May 17, 2022

Ekso Bionics Reports First Quarter 2022 Results

GlobeNewswire April 28, 2022

Ekso Bionics to Report First Quarter 2022 Financial Results on April 28

GlobeNewswire April 21, 2022

Ekso Bionics Reports Fourth Quarter and Year End 2021 Results

GlobeNewswire February 24, 2022

Ekso Bionics to Report Fourth Quarter and Full Year 2021 Financial Results on February 24, 2022

GlobeNewswire February 17, 2022

Ekso Bionics Announces Leadership Transition

GlobeNewswire January 21, 2022

Ekso Bionics Reports Preliminary Fourth Quarter and Full Year 2021 Financial Results

GlobeNewswire January 10, 2022

Ekso Bionics to Participate at the H.C. Wainwright BioConnect Virtual Conference

GlobeNewswire January 4, 2022

Ekso Bionics Appoints Corinna E. Lathan, Ph.D. to its Board of Directors

GlobeNewswire December 28, 2021